`

Intercept Pharmaceuticals

Pharmaceutical Manufacturing

Specialities :
Non-viral liver diseases
Rare diseases
Biotechnology
And innovation
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$447.7M
size-icon Size
201 - 500

Frequently Asked Questions About Intercept Pharmaceuticals

What does Intercept pharmaceuticals do?+

We are a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, including primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with rare and serious liver disease. We are committed to improving patients lives and addressing the liver communitys most pressing needs. Our corporate headquarters is located in New Jersey. For more information about Intercept, please visit our website at: www.interceptpharma.com and...

What are Intercept pharmaceuticals's specialties? +

Non-viral liver diseases,rare diseases,biotechnology,and innovation

What is Intercept pharmaceuticals's industry? +

Intercept pharmaceuticals operates in the Pharmaceutical manufacturing industry.

What is Intercept pharmaceuticals's revenue? +

Intercept pharmaceuticals's revenue is 11m - 100m

What is Intercept pharmaceuticals's company size? +

Intercept pharmaceuticals has 201 - 500 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.